MOUSE MUSCLEBLIND MODEL FOR MYOTONIC DYSTROPHY

强直性肌营养不良小鼠肌盲模型

基本信息

  • 批准号:
    6824697
  • 负责人:
  • 金额:
    $ 29.83万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-09-30 至 2008-05-31
  • 项目状态:
    已结题

项目摘要

The myotonic dystrophies (DM1 and DM2), which are the most common form of adult-onset muscular dystrophy, are autosomal dominant diseases with similar clinical presentations. Remarkably, DM1 and DM2 are caused by unstable microsatellite expansions in the untranslated regions of two different genes, DMPK and ZNF9. To explain how these non-coding expansion mutations lead to dominantly inherited neuromuscular disorders, we have proposed a toxic RNA model for the myotonic dystrophies. Transcription of the mutant DM1 (CTG)n and DM2 (CCTG)n alleles leads to the production of unusual RNA transcripts with (CUG)n and (CCUG)n repeat expansions. These expansions fold into stable double-stranded (ds) RNA structures that recruit and then sequester a family of dsRNA-binding factors, the muscleblind proteins. Because this toxic RNA model suggests that DM1 and DM2 diseases are due to loss of muscleblind protein function, we have derived muscleblind 1 (Mbnl1) knockout mice. This proposal is designed to test our working hypothesis that Mbnl1-/- knockout mice will be a useful model to examine underlying molecular mechanisms involved in myotonic dystrophy disease pathogenesis. First, we will characterize the Mbnl1-/-muscle phenotype and test the hypothesis that Mbnl1 is required for proper alternative splicing and function of the chloride channel CIC-1. Deficiency of this ion channel has been recently implicated as the cause of DM1- and DM2- associated myotonia. The stoichiometric relationship between toxic RNA and binding protein will be examined by breeding Mbnll knockout mice with lines of transgenic mice that express (CUG)n RNA at different levels. Second, the possibility that muscleblind proteins influence CIC-1 chloride channel levels by interacting with alternative splicing, and/or other, factors will be examined. Third, the hypothesis that the myotonia phenotype can berescued using recombinant adeno-associated virus mediated expression of wild type adult CIC-1 will be tested. Finally, we will investigate if additional disease-associated phenotypes result from deletion of the entire Mbnl1 gene, from tissue-specific Mbnl1 expression or from combinatorial loss of all three muscleblind (Mbnl1, Mbnl2/Mbnll, Mbnl3/Mblx) genes.
强直性肌营养不良症(DM 1和DM 2)是成人发病型肌营养不良症中最常见的形式,是具有相似临床表现的常染色体显性遗传疾病。值得注意的是,DM 1和DM 2是由两个不同基因DMPK和ZNF 9的非翻译区中不稳定的微卫星扩展引起的。为了解释这些非编码扩增突变如何导致显性遗传性神经肌肉疾病,我们提出了强直性肌营养不良症的毒性RNA模型。突变体DM 1(CTG)n和DM 2(CCTG)n等位基因的转录导致产生具有(CUG)n和(CCUG)n重复扩增的不寻常的RNA转录物。这些扩展折叠成稳定的双链(ds)RNA结构,招募并随后隔离一个dsRNA结合因子家族,即肌盲蛋白。因为这种有毒RNA模型表明,DM 1和DM 2疾病是由于肌盲蛋白的丢失, 功能,我们已经获得了muscleblind 1(Mbnl 1)基因敲除小鼠。该建议旨在测试我们的工作假设,即Mbnl 1-/-敲除小鼠将是一个有用的模型,以检查参与强直性肌营养不良疾病发病机制的潜在分子机制。首先,我们将描述Mbnl 1-/-肌肉表型和测试的假设,Mbnl 1是需要适当的选择性剪接和氯离子通道CIC-1的功能。这种离子通道的缺乏最近被认为是DM 1和DM 2相关肌强直的原因。毒性RNA和结合蛋白之间的化学计量关系将通过使MbnII敲除小鼠与以不同水平表达(CUG)n RNA的转基因小鼠系繁殖来检查。其次,肌盲蛋白通过与选择性剪接和/或其他因素相互作用影响CIC-1氯离子通道水平的可能性将被检查。三是 将检验使用重组腺相关病毒介导的野生型成人CIC-1表达可以挽救肌强直表型的假设。最后,我们将调查是否额外的疾病相关表型的结果从整个Mbnl 1基因的缺失,从组织特异性Mbnl 1表达或从所有三个肌盲(Mbnl 1,Mbnl 2/Mbnll,Mbnl 3/Mblx)基因的组合损失。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MAURICE SCOTT SWANSON其他文献

MAURICE SCOTT SWANSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MAURICE SCOTT SWANSON', 18)}}的其他基金

Therapeutic strategies for microsatellite expansion diseases using RNA-targeting CRISPR/Cas
使用 RNA 靶向 CRISPR/Cas 治疗微卫星扩增疾病的策略
  • 批准号:
    10171924
  • 财政年份:
    2017
  • 资助金额:
    $ 29.83万
  • 项目类别:
Therapeutic strategies for microsatellite expansion diseases using RNA targeting
利用 RNA 靶向治疗微卫星扩增疾病的策略
  • 批准号:
    10588064
  • 财政年份:
    2017
  • 资助金额:
    $ 29.83万
  • 项目类别:
MECHANISMS OF RNA-MEDIATED CNS PATHOGENESIS IN MYOTONIC DYSTOPHY
RNA介导的强直性肌营养不良中枢神经系统发病机制
  • 批准号:
    8609101
  • 财政年份:
    2008
  • 资助金额:
    $ 29.83万
  • 项目类别:
MECHANISMS OF RNA-MEDIATED CNS PATHOGENESIS IN MYOTONIC DYSTOPHY
RNA介导的强直性肌营养不良中枢神经系统发病机制
  • 批准号:
    9105456
  • 财政年份:
    2008
  • 资助金额:
    $ 29.83万
  • 项目类别:
MECHANISMS OF RNA-MEDIATED CNS PATHOGENESIS IN MYOTONIC DYSTOPHY
RNA介导的强直性肌营养不良中枢神经系统发病机制
  • 批准号:
    8739678
  • 财政年份:
    2008
  • 资助金额:
    $ 29.83万
  • 项目类别:
Preclinical models, biomarkers, and therapy for myotonic dystrophy type 1
1 型强直性肌营养不良的临床前模型、生物标志物和治疗
  • 批准号:
    10021453
  • 财政年份:
    2003
  • 资助金额:
    $ 29.83万
  • 项目类别:
Preclinical models, biomarkers, and therapy for myotonic dystrophy type 1
1 型强直性肌营养不良的临床前模型、生物标志物和治疗
  • 批准号:
    10480097
  • 财政年份:
    2003
  • 资助金额:
    $ 29.83万
  • 项目类别:
Preclinical models, biomarkers, and therapy for myotonic dystrophy type 1
1 型强直性肌营养不良的临床前模型、生物标志物和治疗
  • 批准号:
    10237267
  • 财政年份:
    2003
  • 资助金额:
    $ 29.83万
  • 项目类别:
RNA DOMINANCE IN HUMAN DISEASE
RNA 在人类疾病中的优势
  • 批准号:
    6632761
  • 财政年份:
    2000
  • 资助金额:
    $ 29.83万
  • 项目类别:
RNA Dominance in Human Disease
RNA 在人类疾病中的主导地位
  • 批准号:
    7600482
  • 财政年份:
    2000
  • 资助金额:
    $ 29.83万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了